Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting

NCT04128501

Conditions: Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, +18 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

NCT04176718

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +19 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

NCT03422731

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +12 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

NCT01860937

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +15 more
Locations: Dana-Farber Cancer Institute:Dana- Farber/Children's Hospital Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, not recruiting

A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia

NCT01683279

Conditions: B Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, not recruiting

Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma

NCT05363800

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
Locations: Henan cancer Hospital Zhengzhou, Henan, China

Sheng Jing Hospital of China Medical University Shengyang, Liaoning, China

Zhejiang University School of Medicine The First Affiliated Hospital Hangzhou, Zhejiang, China

View Trial Details

Active, not recruiting

MMRC Horizon One: RRMM (MMRC-099)

NCT06171685

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: City of Hope Duarte, California, United States

Emory Winship Cancer Center Atlanta, Georgia, United States

University of Chicago Cancer Center Chicago, Illinois, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View all 13 locations

View Trial Details

Active, not recruiting

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

NCT05723055

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States

View Trial Details

Active, not recruiting

Loncastuximab Tesirine and Venetoclax for Relapsed/ Refractory Non-Hodgkin Lymphoma

NCT05053659

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Active, not recruiting

Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia

NCT03186118

Conditions: CD 19+ Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions